Search

Your search keyword '"Langhorst, J"' showing total 688 results
Start Over Author "Langhorst, J"
688 results on '"Langhorst, J"'

3. Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.2).

Author

Kucharzik, T., Dignass, A., Atreya, R., Bokemeyer, B., Esters, P., Herrlinger, K., Kannengiesser, K., Kienle, P., Langhorst, J., Lügering, A., Schreiber, S., Stallmach, A., Stein, J., Sturm, A., Teich, N., Siegmund, B., Andus, T., Autschbach, F., Bachmann, O., and Baretton, G.

Published
2024
Full Text
View/download PDF

5. Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.1) – Februar 2023 – AWMF-Registriernummer: 021-009

Author

Kucharzik, T, Dignass, A, Atreya, R, Bokemeyer, B, Esters, P, Herrlinger, K, Kannengiesser, K, Kienle, P, Langhorst, J, Lügering, A, Schreiber, S, Stallmach, A, Stein, J, Sturm, A, Teich, N, Siegmund, B, Kucharzik, T, Dignass, A, Atreya, R, Bokemeyer, B, Esters, P, Herrlinger, K, Kannengiesser, K, Kienle, P, Langhorst, J, Lügering, A, Schreiber, S, Stallmach, A, Stein, J, Sturm, A, Teich, N, and Siegmund, B

Published
2023

11. 7. Konzepte der nichtmedikamentösen Therapie

Author

Mazurak, N., primary, Enck, P., additional, Madisch, A., additional, Lee, I., additional, Musial, F., additional, Langhorst, J., additional, Koch, A. K., additional, van der Voort, I., additional, Schwille-Kiuntke, J., additional, Moser, G., additional, Peter, J., additional, Fuchs, K.-H., additional, Babic, B., additional, Breithaupt, W., additional, Frieling, T., additional, and Goebel-Stengel, M., additional

Published
2017
Full Text
View/download PDF

14. S3-Guideline on Diverticular Disease/Diverticulitis - Joint Guideline of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) and the German Society of General and Visceral Surgery (DGAV) November 2021-AWMF Register Number: 021-20

Author

Leifeld, Ludger, Germer, Christoph-Thomas, Boehm, Stephan, Dumoulin, Franz Ludwig, Frieling, Thomas, Kreis, Martin, Meining, Alexander, Labenz, Joachim, Lock, Johan Friso, Ritz, Joerg-Peter, Schreyer, Andreas, Kruis, Wolfgang, Aigner, F., Allescher, H., Eckmann, C., Hampe, J., Hartmann, F., Helwig, U., Hoffmann, J., Keller, J., Langhorst, J., Lauscher, J., Lorenz, P., Jansen, P. Lynen, Madisch, A., Neumann, J., Pelz, J., Reinshagen, M., Reissfelder, C., Rubin, D., Sander, C., Schaefer, A., Schiedeck, T., Schwenk, W., Siegmund, B., Steubesand, N., Tappe, U., Willis, S., Leifeld, Ludger, Germer, Christoph-Thomas, Boehm, Stephan, Dumoulin, Franz Ludwig, Frieling, Thomas, Kreis, Martin, Meining, Alexander, Labenz, Joachim, Lock, Johan Friso, Ritz, Joerg-Peter, Schreyer, Andreas, Kruis, Wolfgang, Aigner, F., Allescher, H., Eckmann, C., Hampe, J., Hartmann, F., Helwig, U., Hoffmann, J., Keller, J., Langhorst, J., Lauscher, J., Lorenz, P., Jansen, P. Lynen, Madisch, A., Neumann, J., Pelz, J., Reinshagen, M., Reissfelder, C., Rubin, D., Sander, C., Schaefer, A., Schiedeck, T., Schwenk, W., Siegmund, B., Steubesand, N., Tappe, U., and Willis, S.

Published
2022

18. Aktualisierte S2k-Leitlinie chronische Obstipation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie & Motilität (DGNM) – April 2022 – AWMF-Registriernummer: 021–019

Author

Andresen, V., Becker, G., Frieling, T., Goebel-Stengel, M., Gundling, F., Herold, A., Karaus, M., Keller, J., Kim, M., Klose, P., Krammer, H., Kreis, M. E., Kuhlbusch-Zicklam, R., Langhorst, J., Layer, P., Lenzen-Großimlinghaus, R., Madisch, A., Mönnikes, H., Müller-Lissner, S., and Rubin, D.

Published
2022
Full Text
View/download PDF

33. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome

Author

Kaiser, T., Langhorst, J., Wittkowski, H., Becker, K., Friedrich, A.W., Rueffer, A., Dobos, G.J., Roth, J., and Foell, D.

Subjects
Inflammatory bowel diseases -- Diagnosis, Inflammatory bowel diseases -- Development and progression, Irritable bowel syndrome -- Diagnosis, Irritable bowel syndrome -- Development and progression, Biological markers -- Research, DNA binding proteins -- Physiological aspects, DNA binding proteins -- Research, Enzyme-linked immunosorbent assay -- Usage, Health
Published
2007

35. Perceived stress mediates the effect of yoga on quality of life and disease activity in ulcerative colitis. Secondary analysis of a randomized controlled trial.

Author

Koch AK, Schöls M, Langhorst J, Dobos G, Cramer H, Koch AK, Schöls M, Langhorst J, Dobos G, and Cramer H

Abstract

OBJECTIVE:Yoga positively affects health-related quality of life and disease activity in ulcerative colitis. The underlying modes of action remain unclear. Within the present study we hypothesized that patients´ perceived stress mediates the effects of yoga on health-related quality of life and disease activity. METHODS:This is a secondary analysis of a randomized controlled trial comparing the effects of yoga to written self-care advice in patients with inactive ulcerative colitis and impaired quality of life. Perceived stress was assessed using the Perceived Stress Questionnaire, health-related quality of life using the Inflammatory Bowel Disease Questionnaire and disease activity using the Clinical Activity Index. Outcomes were assessed at weeks 0, 12 and 24. RESULTS:Seventy-seven patients participated. Thirty-nine patients attended the 12 supervised weekly yoga sessions (71.8% women; 45.0 ± 13.3 years) and 38 patients written self-care advice (78.9% women; 46.1 ± 10.4 years). Perceived stress correlated significantly with health-related quality of life and disease activity at week 24. Perceived stress at week 12 fully mediated the effects of yoga on health-related quality of life (B = 16.23; 95% Confidence interval [6.73; 28.40]) and disease activity (B = -0.28; 95% Confidence interval [-0.56; -0.06]) at week 24. CONCLUSION:Our findings confirm the importance of perceived stress in reducing disease activity and increasing health-related quality of life in patients with ulcerative colitis and impaired quality of life. Practitioners should keep psychosocial risk in mind as a risk factor for disease exacerbation, and consider yoga as an adjunct intervention for highly stressed patients with ulcerative colitis. CLINICALTRIALS. GOV REGISTRATION NUMBER:The trial was registered at clinicaltrials.gov prior to patient recruitment (registration number NCT02043600).

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results